Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which chemotherapy regimen is more effective for cervical cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of three different
chemotherapy regimens in treating patients with stage IVB, recurrent, or persistent cervical
cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Gynecologic Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI)